Patents by Inventor Peter Sayre

Peter Sayre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant DNA-produced T11 and fragments thereof
    Patent number: 5830754
    Abstract: A cDNA sequence encoding human T11 or a fragment thereof which is capable of inhibiting T-lymphocyte activation.
    Type: Grant
    Filed: December 21, 1994
    Date of Patent: November 3, 1998
    Assignee: Dana-Farber Cancer Institute
    Inventors: Ellis Reinherz, Peter Sayre, Hsiu-Ching Chang, Neil Richardson
  • Recombinant DNA-produced T11 and fragments thereof
    Patent number: 5608037
    Abstract: A cDNA sequence encoding human T11 or a fragment thereof which is capable of inhibiting T-lymphocyte activation.
    Type: Grant
    Filed: May 18, 1995
    Date of Patent: March 4, 1997
    Assignee: Dana Farber Cancer Institute
    Inventors: Ellis Reinherz, Peter Sayre, Hsiu-Ching Chang, Neil Richardson
  • Recombinant DNA-produced T11 and fragments thereof
    Patent number: 5550055
    Abstract: A cDNA sequence encoding human T11 or a fragment thereof which is capable of inhibiting T-lymphocyte activation.
    Type: Grant
    Filed: May 24, 1995
    Date of Patent: August 27, 1996
    Assignee: Dana-Farber Cancer Institute
    Inventors: Ellis Reinherz, Peter Sayre, Hsiu-Ching Chang, Neil Richardson